Asferd Mengesha

651 total citations
9 papers, 497 citations indexed

About

Asferd Mengesha is a scholar working on Biotechnology, Genetics and Cancer Research. According to data from OpenAlex, Asferd Mengesha has authored 9 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biotechnology, 6 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Asferd Mengesha's work include Virus-based gene therapy research (6 papers), Cancer Research and Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Asferd Mengesha is often cited by papers focused on Virus-based gene therapy research (6 papers), Cancer Research and Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Asferd Mengesha collaborates with scholars based in Netherlands, Belgium and Australia. Asferd Mengesha's co-authors include Jozef Anné, Wei Ming, David A. Good, Jan Theys, Qin Yao, Ludwig J. Dubois, Beihua Kong, Willy Landuyt, Philippe Lambin and Siyu Cao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Asferd Mengesha

9 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asferd Mengesha Netherlands	8	317	200	176	153	98	9	497
Nele Van Dessel United States	13	246 0.8×	202 1.0×	107 0.6×	263 1.7×	20 0.2×	16	509
Mai T. Duong South Korea	7	399 1.3×	336 1.7×	136 0.8×	125 0.8×	60 0.6×	10	606
Simon Rajendran Ireland	9	151 0.5×	79 0.4×	125 0.7×	147 1.0×	17 0.2×	38	364
B Bentley United States	5	147 0.5×	119 0.6×	62 0.4×	349 2.3×	46 0.5×	5	529
Christopher Plescia United States	4	175 0.6×	147 0.7×	63 0.4×	188 1.2×	12 0.1×	7	429
Arthee Jahangir United States	8	235 0.7×	181 0.9×	80 0.5×	174 1.1×	23 0.2×	11	618
Sara Collins United States	9	99 0.3×	64 0.3×	122 0.7×	160 1.0×	14 0.1×	19	290
Wenguang Wang China	7	84 0.3×	108 0.5×	32 0.2×	143 0.9×	81 0.8×	14	319
Sarah Jezzard United Kingdom	12	125 0.4×	41 0.2×	297 1.7×	318 2.1×	17 0.2×	14	592
Cristian Capasso Finland	16	119 0.4×	114 0.6×	324 1.8×	388 2.5×	68 0.7×	23	709

Countries citing papers authored by Asferd Mengesha

Since Specialization

Citations

This map shows the geographic impact of Asferd Mengesha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asferd Mengesha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asferd Mengesha more than expected).

Fields of papers citing papers by Asferd Mengesha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asferd Mengesha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asferd Mengesha. The network helps show where Asferd Mengesha may publish in the future.

Co-authorship network of co-authors of Asferd Mengesha

This figure shows the co-authorship network connecting the top 25 collaborators of Asferd Mengesha. A scholar is included among the top collaborators of Asferd Mengesha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asferd Mengesha. Asferd Mengesha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Yao, Qin, Siyu Cao, Chun Li, et al.. (2010). Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers. Biochemical and Biophysical Research Communications. 398(3). 413–419. 15 indexed citations

Yao, Qin, et al.. (2010). Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction. International Journal of Cancer. 128(8). 1783–1792. 101 indexed citations

Dubois, Ludwig J., Tom Dresselaers, Willy Landuyt, et al.. (2007). Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression. British Journal of Cancer. 96(5). 758–761. 10 indexed citations

Mengesha, Asferd. (2007). Potential and limitations of bacterial-mediated cancer therapy. Frontiers in bioscience. 12(8-12). 3880–3880. 39 indexed citations

Ming, Wei, Asferd Mengesha, David A. Good, & Jozef Anné. (2007). Bacterial targeted tumour therapy-dawn of a new era. Cancer Letters. 259(1). 16–27. 116 indexed citations

Groot, Arjan J., Asferd Mengesha, Elsken van der Wall, et al.. (2007). Functional antibodies produced by oncolytic clostridia. Biochemical and Biophysical Research Communications. 364(4). 985–989. 47 indexed citations

Mengesha, Asferd, Ludwig J. Dubois, Philippe Lambin, et al.. (2006). Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonella. Cancer Biology & Therapy. 5(9). 1120–1128. 70 indexed citations

Theys, Jan, Oliver Pennington, Ludwig J. Dubois, et al.. (2006). Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. British Journal of Cancer. 95(9). 1212–1219. 98 indexed citations

Mengesha, Asferd, et al.. (1991). PREVALENCE OF ANEMIA AMONG ELEMENTARY AND HIGH SCHOOL STUDENTS LIVING IN GORGORA. Ethiopian Journal of Health Development. 5(1). 43–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact